Physician

Heidi Clare Piper, M.D.

According to 2025 Medicare claims, Heidi Piper, M.D. (NPI: 1558364430) practices ophthalmology in the Rochester, NY market, with the plurality of this provider's patient population coming from Ontario, NY. This provider's primary affiliated billing organization is FINGER LAKES OPHTHALMOLOGY, PC (NPI: 1447253315; TIN: 161233573) and primary practice location at 14424-1723.

Piper's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 349 traditional Medicare patients, billed 23,047 HCPCS/CPT codes, and received $1,664,876 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,263 prescription claims across 330 beneficiaries totaling $61,531 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 25 records totaling $479. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,108,467 to $1,664,876. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$867K$1.7M2015 Medicare payment: $1,108,467 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,095,671 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,256,114 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,615,697 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,733,024 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,687,573 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,688,658 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,633,007 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,668,533 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,664,876 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154536,011$1,108,467
20164605,889$1,095,671
20174876,171$1,256,114
20185036,862$1,615,697
20194506,649$1,733,024
20203966,693$1,687,573
20213856,554$1,688,658
20223698,952$1,633,007
202334819,497$1,668,533
202434923,047$1,664,876

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$85K$171K2015 Drug cost: $98,411 (USD; Tot_Drug_Cst)2016 Drug cost: $96,321 (USD; Tot_Drug_Cst)2017 Drug cost: $107,092 (USD; Tot_Drug_Cst)2018 Drug cost: $136,958 (USD; Tot_Drug_Cst)2019 Drug cost: $170,811 (USD; Tot_Drug_Cst)2020 Drug cost: $117,927 (USD; Tot_Drug_Cst)2021 Drug cost: $104,561 (USD; Tot_Drug_Cst)2022 Drug cost: $105,426 (USD; Tot_Drug_Cst)2023 Drug cost: $84,617 (USD; Tot_Drug_Cst)2024 Drug cost: $61,531 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153161,216$98,411
20163681,380$96,321
20174091,364$107,092
20185251,869$136,958
20195721,952$170,811
20204261,474$117,927
20214381,428$104,561
20224461,558$105,426
20233821,370$84,617
20243301,263$61,531

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1171,170$651
67028Injection of drug into eye2111,021$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more251403$63
J9035Injection, bevacizumab, 10 mg51170$45
92134Imaging of retina3191,250$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XiidraLifitegrast13390$9,154
LumiganBimatoprost231,185$8,994
Prednisolone AcetatePrednisolone Acetate1986,146$6,175
TravoprostTravoprost261,225$5,781
LatanoprostLatanoprost32615,777$2,867

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$479Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Heidi Clare Piper, M.D.?

Tedicare shows public-source Medicare data for Heidi Clare Piper, M.D. (NPI 1558364430), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Heidi Clare Piper, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Heidi Clare Piper, M.D.?

Heidi Clare Piper, M.D. is linked to FINGER LAKES OPHTHALMOLOGY, PC (billing NPI 1447253315) in the available physician profile data.

Does Heidi Clare Piper, M.D. have Open Payments data?

Heidi Clare Piper, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.